General Information of This Antigen (ID: TAR0ZHRFU)
Antigen Name
Glutamate carboxypeptidase 2 (FOLH1)
Gene Name
FOLH1
Gene ID
2346
Synonym
Cell growth-inhibiting gene 27 protein; Folate hydrolase 1; Folylpoly-gamma-glutamate carboxypeptidase; Glutamate carboxypeptidase II; Membrane glutamate carboxypeptidase; N-acetylated-alpha-linked acidic dipeptidase I; Prostate-specific membrane antigen; Pteroylpoly-gamma-glutamate carboxypeptidase
Sequence
MWNLLHETDSAVA.RPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKAFL
DELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNK
THPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYART
EDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSY
PDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDA
QKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTL
RGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWD
AEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELK
SPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWE
TNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAV
VLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLR
MMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPS
KAWGEVKRQIYVAAFTVQAAAETLSEVA

    Click to Show/Hide
Family
Peptidase M28 family
Function
Has both folate hydrolase and N-acetylated-alpha-linked- acidic dipeptidase (NAALADase) activity. Has a preference for tri- alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Involved in prostate tumor progression.; Also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.

    Click to Show/Hide
Uniprot Entry
FOLH1_HUMAN
HGNC ID
HGNC:3788
KEGG ID
hsa:2346
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
ADC Name Payload Target Linker ADC Info
38751786 5D3 (CC-MLB8237)3.2 ATC [1]
MLN8237
Undisclosed
NHS-PEG-TCO-Tz
5D3 mAb-AF488
ADC Name Payload Target Linker ADC Info
38751786 5D3 (CC-MLB8237)3.2-AF488 [1]
MLN8237
Undisclosed
NHS-PEG-TCO-Tz
5D3 mAb-AF555
ADC Name Payload Target Linker ADC Info
38751786 5D3 (CC-MLB8237)3.2-AF555 [1]
MLN8237
Undisclosed
NHS-PEG-TCO-Tz
5D3 mAb-CF750
ADC Name Payload Target Linker ADC Info
38751786 5D3 (CC-MLB8237)3.2-CF750 [1]
MLN8237
Undisclosed
NHS-PEG-TCO-Tz
ADC Name Payload Target Linker ADC Info
Monoclonal antibody 7E11 C5-selenocystamine conjugate [2]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
H8-LD12 [3]
Undisclosed
Undisclosed
Undisclosed
H8-LD3 [3]
Undisclosed
Undisclosed
Undisclosed
H8-LD4 [3]
Undisclosed
Undisclosed
Undisclosed
H8-LD5 [3]
Undisclosed
Undisclosed
Undisclosed
H8-LD6 [3]
Undisclosed
Undisclosed
Undisclosed
H8-LD7 [3]
Undisclosed
Undisclosed
Undisclosed
H8-LD8 [3]
Undisclosed
Undisclosed
Undisclosed
Anti-PSMA
ADC Name Payload Target Linker ADC Info
PSMA -LD12 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA -LD3 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA -LD4 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA -LD5 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA -LD6 [3]
Undisclosed
Undisclosed
Undisclosed
Anti-PSMA antibody
ADC Name Payload Target Linker ADC Info
MHB048C [4]
MH30010008
DNA topoisomerase 1 (TOP1)
Undisclosed
Anti-PSMA IgG1 mAb D2B
ADC Name Payload Target Linker ADC Info
111In-DTPA-D2B-DAR4-MMAE [5]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
111In-DTPA-D2B-DAR2-MMAE [5]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-PSMA IgG1k mAb
ADC Name Payload Target Linker ADC Info
JNJ-95298177
Amberstatin 269 (AS269)
Microtubule (MT)
Oxime-PEG3
Anti-PSMA mAb
ADC Name Payload Target Linker ADC Info
PSMA-15 [6]
DM1 derivative 15
Microtubule (MT)
Mc-Val-Cit-PABC
PSMA-16 [6]
DM1 derivative 16
Microtubule (MT)
Mc-Val-Cit-PABC
SHR-4394
SHR9265
DNA topoisomerase 1 (TOP1)
A cleavable linker
Anti-PSMA mAb 5D3
ADC Name Payload Target Linker ADC Info
111In-DOTA-5D3 [7]
Indium-111
Human Deoxyribonucleic acid (hDNA)
Tetraxetan
Anti-PSMA mAb D2B
ADC Name Payload Target Linker ADC Info
D2B-DCM [8]
Duocarmycin A
Human Deoxyribonucleic acid (hDNA)
Mc-Val-Cit-PABC
Anti-PSMA mAb h3/F11-Var16
ADC Name Payload Target Linker ADC Info
H3/F11-Var16 (Anti-PSMA)-30.2060 [9]
Amanitin 30.206
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
H3/F11-Var16 (Anti-PSMA)-30.2867 [9]
Amanitin 30.2867
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Maleimido-caproyl
Anti-PSMA mAb hD7-1
ADC Name Payload Target Linker ADC Info
HD7-1 (VL-VH)-PE40 [10]
Pseudomonas exotoxin PE40
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
HD7-1 (VL-VH)-PE24 [10]
Pseudomonas exotoxin PE24
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
HD7-1 (VL-VH)-PE24mut [10]
Pseudomonas exotoxin PE24 mut
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
Anti-PSMA mAb wt
ADC Name Payload Target Linker ADC Info
SYD998 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
WO2015177360A1 ADC-wt-vcMMAE [11]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2015177360A1 ADC-wt-mcMMAF [11]
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
Anti-PSMA mAb wt HC A339C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC339 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC D376C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC376 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC E152C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC152 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC G236C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC236 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC P153C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC153 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC P247C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC247 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC S375C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC375 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC S41C
ADC Name Payload Target Linker ADC Info
SYD1091 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
WO2015177360A1 ADC-HC41-vcMMAE [11]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2015177360A1 ADC-HC41-mcMMAF [11]
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
Anti-PSMA mAb wt HC S41C/S375C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC41-375 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC S41C/T120C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-HC41-120 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt HC T120C
ADC Name Payload Target Linker ADC Info
SYD1035 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt LC E165C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-LC205 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt LC G157C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-LC157 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt LC G41C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-LC41 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
WO2015177360A1 ADC-LC41-vcMMAE [11]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2015177360A1 ADC-LC41-mcMMAF [11]
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
Anti-PSMA mAb wt LC L154C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-LC165 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt LC P40C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-LC154 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
WO2015177360A1 ADC-LC40-vcMMAE [11]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2015177360A1 ADC-LC40-mcMMAF [11]
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
Anti-PSMA mAb wt LC T109C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-LC109 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA mAb wt LC V205C
ADC Name Payload Target Linker ADC Info
WO2015177360A1 ADC-LC40 [11]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Anti-PSMA scFv
ADC Name Payload Target Linker ADC Info
124I-scFvD2B [12]
Iodine I-124
Undisclosed
Undisclosed
Anti-PSMA-D265C
ADC Name Payload Target Linker ADC Info
Anti-PSMA-D265C-30.2060 [9]
Amanitin 30.206
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-PSMA-D265C-30.2115 [9]
Amanitin 30.2115
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-PSMA-D265C-30.2347 [9]
Amanitin 30.2347
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-PSMA-D265C-30.1699 [9]
Amanitin 30.1699
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-PSMA-D265C-30.2371 [9]
Amanitin 30.2371
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-PSMA-D265C-30.0880 [9]
Amanitin 30.088
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Maleimido-caproyl
Anti-PSMA-D265C-30.2867 [9]
Amanitin 30.2867
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Maleimido-caproyl
Anti-PSMA-HC1205
ADC Name Payload Target Linker ADC Info
PSMA-HC1205-LD12 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC1205-LD3 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC1205-LD4 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC1205-LD5 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC1205-LD6 [3]
Undisclosed
Undisclosed
Undisclosed
Anti-PSMA-HC41
ADC Name Payload Target Linker ADC Info
PSMA-HC41-LD12 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC41-LD3 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC41-LD4 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC41-LD5 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC41-LD6 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC41-LD7 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC41-LD8 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-HC41-LD9 [3]
Undisclosed
Undisclosed
PSMA-HC41-LD9 LINKER
PSMA-HC41-LD10 [3]
Undisclosed
Undisclosed
Trastuzumab-LD1-LINKER
PSMA-HC41-LD36 [3]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
PSMA-HC41-LD36 LINKER
PSMA-HC41-LD64 [3]
PSMA-HC41-LD64 payload
Undisclosed
PSMA-HC41-LD64 LINKER
Anti-PSMA-LC40
ADC Name Payload Target Linker ADC Info
PSMA-LC40-LD12 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC40-LD3 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC40-LD4 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC40-LD5 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC40-LD6 [3]
Undisclosed
Undisclosed
Undisclosed
Anti-PSMA-LC41
ADC Name Payload Target Linker ADC Info
PSMA-LC41-LD12 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC41-LD3 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC41-LD4 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC41-LD5 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA-LC41-LD6 [3]
Undisclosed
Undisclosed
Undisclosed
Anti-PSMA1
ADC Name Payload Target Linker ADC Info
PSMA1 -LD12 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA 1-LD3 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA 1-LD4 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA 1-LD5 [3]
Undisclosed
Undisclosed
Undisclosed
PSMA 1-LD6 [3]
Undisclosed
Undisclosed
Undisclosed
Chimeric Anti-PSMA Antibody
ADC Name Payload Target Linker ADC Info
EP4461318A2 anti-PSMA ADC11 [13]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
EP4461318A2 anti-PSMA ADC12 [13]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
EP4461318A2 anti-PSMA ADC13 [13]
Monomethyl auristatin F
Microtubule (MT)
CLeavable (Val-Citruline-PEG1) linker
EP4461318A2 anti-PSMA ADC14 [13]
Monomethyl auristatin F
Microtubule (MT)
Short Cleavable (Valine-Citruline-Acetyl)
EP4461318A2 anti-PSMA ADC15 [13]
Monomethyl auristatin E
Microtubule (MT)
Short Cleavable (Valine-Citruline-Acetyl)
ADC Name Payload Target Linker ADC Info
SDV2102 [14]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Fully human anti-PSMA IgG1 mAb
ADC Name Payload Target Linker ADC Info
PSMA ADC
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
TD001 [15]
Exatecan
DNA topoisomerase 1 (TOP1)
A cleavable linker
Humanized Anti-PSMA Antibody Variant 1
ADC Name Payload Target Linker ADC Info
EP4461318A2 anti-PSMA ADC1 [13]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
EP4461318A2 anti-PSMA ADC2 [13]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
EP4461318A2 anti-PSMA ADC3 [13]
Monomethyl auristatin F
Microtubule (MT)
CLeavable (Val-Citruline-PEG1) linker
EP4461318A2 anti-PSMA ADC4 [13]
Monomethyl auristatin F
Microtubule (MT)
Short Cleavable (Valine-Citruline-Acetyl)
EP4461318A2 anti-PSMA ADC5 [13]
Monomethyl auristatin E
Microtubule (MT)
Short Cleavable (Valine-Citruline-Acetyl)
Humanized Anti-PSMA Antibody Variant 2
ADC Name Payload Target Linker ADC Info
EP4461318A2 anti-PSMA ADC6 [13]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
EP4461318A2 anti-PSMA ADC7 [13]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
EP4461318A2 anti-PSMA ADC8 [13]
Monomethyl auristatin F
Microtubule (MT)
CLeavable (Val-Citruline-PEG1) linker
EP4461318A2 anti-PSMA ADC9 [13]
Monomethyl auristatin F
Microtubule (MT)
Short Cleavable (Valine-Citruline-Acetyl)
EP4461318A2 anti-PSMA ADC10 [13]
Monomethyl auristatin E
Microtubule (MT)
Short Cleavable (Valine-Citruline-Acetyl)
Humanized anti-PSMA IgG1k mAb
ADC Name Payload Target Linker ADC Info
ARX-517
Amberstatin-269
Undisclosed
Oxime-PEG3
ADC Name Payload Target Linker ADC Info
MEDI3726
SG3199 (SC-DR002)
Human deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
YC1613 [16]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Ab-MC-VC-PAB-DMEDA-PEG (N3)-SN38 Linker
YC1628 [16]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Ab-MP2-VC-PAB-DMEDA-PEG (N3)-SN38 Linker
YC1605 [16]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
YC1667 [16]
MK4827
Undisclosed
Ab-MC-MMAF-VC-PAB-MK4827 Linker
YC1663 [16]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Ab-MC-MMAF-VC-PAB-DMEDA-PEG (N3)-SN38 Linker
J591 THIOMAB
ADC Name Payload Target Linker ADC Info
J591 DAC [17]
GNE-987 (R)
Bromodomain-containing protein 4 (BRD4)
Mc-Gly-Gly-Phe-Gly
J591-SC239C
ADC Name Payload Target Linker ADC Info
PSMA-D Antibody-Compound (X) [18]
PSMA-D Antibody-Compound (X) payload
Undisclosed
PSMA-D Antibody-Compound (X) linker
PSMA-D Antibody-Compound (XI) [18]
PSMA-D Antibody-Compound (XI) payload
Undisclosed
PSMA-D Antibody-Compound (XI) linker
PSMA-D Antibody-Compound (XIV) [18]
PSMA-D Antibody-Compound (XIV) payload
Undisclosed
PSMA-D Antibody-Compound (XIV) linker
PSMA-D Antibody-Compound (XVIII) [18]
PSMA-D Antibody-Compound (XVIII) payload
Undisclosed
PSMA-D Antibody-Compound (XVIII) linker
PSMA-D Antibody-Compound (Ie) [18]
PSMA-D Antibody-Compound (Ie) payload
Undisclosed
PSMA-D Antibody-Compound (Ie) linker
PSMA-D Antibody-Compound (XIX) [18]
PSMA-D Antibody-Compound (XIX) payload
Undisclosed
PSMA-D Antibody-Compound (XIX) linker
PSMA-D Antibody-Compound (Ii) [18]
PSMA-D Antibody-Compound (Ii) payload
Undisclosed
PSMA-D Antibody-Compound (Ii) linker
PSMA-D Antibody-Compound (XLI) [18]
PSMA-D Antibody-Compound (XLI) payload
Undisclosed
PSMA-D Antibody-Compound (XLI) linker
PSMA-D Antibody-Compound (XVI) [18]
PSMA-D Antibody-Compound (XIX) payload
Undisclosed
PSMA-D Antibody-Compound (XIX) linker
PSMA-D Antibody-Compound (XL) [18]
PSMA-D Antibody-Compound (XL) payload
Undisclosed
PSMA-D Antibody-Compound (XL) linker
PSMA-D Antibody-Compound (XLIII) [18]
PSMA-D Antibody-Compound (XLIII) payload
Undisclosed
PSMA-D Antibody-Compound (XLIII) linker
PSMA-D Antibody-Compound (XLII) [18]
PSMA-D Antibody-Compound (XLII) payload
Undisclosed
PSMA-D Antibody-Compound (XLII) linker
J591-SC239C-Compound (XV) [18]
J591-SC239C-Compound (XV) payload
Undisclosed
J591-SC239C-Compound (XV) linker
ADC Name Payload Target Linker ADC Info
MLN2704
DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
PSMA-A Anti-ody
ADC Name Payload Target Linker ADC Info
PSMA-A Antibody-Compound (X) [18]
PSMA-A Antibody-Compound (X) payload
Undisclosed
PSMA-A Antibody-Compound (X) linker
PSMA-A Antibody-Compound (XI) [18]
PSMA-A Antibody-Compound (XI) payload
Undisclosed
PSMA-A Antibody-Compound (XI) linker
PSMA-A Antibody-Compound (XIV) [18]
PSMA-A Antibody-Compound (XIV) payload
Undisclosed
PSMA-A Antibody-Compound (XIV) linker
PSMA-A Antibody-Compound (XVIII) [18]
PSMA-A Antibody-Compound (XVIII) payload
Undisclosed
PSMA-A Antibody-Compound (XVIII) linker
PSMA-A Antibody-Compound (Ie) [18]
PSMA-A Antibody-Compound (Ie) payload
Undisclosed
PSMA-A Antibody-Compound (Ie) linker
PSMA-A Antibody-Compound (XIX) [18]
PSMA-A Antibody-Compound (XIX) payload
Undisclosed
PSMA-A Antibody-Compound (XIX) linker
PSMA-A Antibody-Compound (Ii) [18]
PSMA-A Antibody-Compound (Ii) payload
Undisclosed
PSMA-A Antibody-Compound (Ii) linker
PSMA-A Antibody-Compound (XLI) [18]
PSMA-A Antibody-Compound (XLI) payload
Undisclosed
PSMA-A Antibody-Compound (XLI) linker
PSMA-A Antibody-Compound (XVI) [18]
PSMA-A Antibody-Compound (XIX) payload
Undisclosed
PSMA-A Antibody-Compound (XIX) linker
PSMA-A Antibody-Compound (XL) [18]
PSMA-A Antibody-Compound (XL) payload
Undisclosed
PSMA-A Antibody-Compound (XL) linker
PSMA-A Antibody-Compound (XLIII) [18]
PSMA-A Antibody-Compound (XLIII) payload
Undisclosed
PSMA-A Antibody-Compound (XLIII) linker
PSMA-A Antibody-Compound (XLII) [18]
PSMA-A Antibody-Compound (XLII) payload
Undisclosed
PSMA-A Antibody-Compound (XLII) linker
PSMA-A Antibody-Compound (XV) [18]
PSMA-A Antibody-Compound (XV) payload
Undisclosed
PSMA-A Antibody-Compound (XV) linker
PSMA-B Anti-ody
ADC Name Payload Target Linker ADC Info
PSMA-B Antibody-Compound (X) [18]
PSMA-B Antibody-Compound (X) payload
Undisclosed
PSMA-B Antibody-Compound (X) linker
PSMA-B Antibody-Compound (XI) [18]
PSMA-B Antibody-Compound (XI) payload
Undisclosed
PSMA-B Antibody-Compound (XI) linker
PSMA-B Antibody-Compound (XIV) [18]
PSMA-B Antibody-Compound (XIV) payload
Undisclosed
PSMA-B Antibody-Compound (XIV) linker
PSMA-B Antibody-Compound (XVIII) [18]
PSMA-B Antibody-Compound (XVIII) payload
Undisclosed
PSMA-B Antibody-Compound (XVIII) linker
PSMA-B Antibody-Compound (Ie) [18]
PSMA-B Antibody-Compound (Ie) payload
Undisclosed
PSMA-B Antibody-Compound (Ie) linker
PSMA-B Antibody-Compound (XIX) [18]
PSMA-B Antibody-Compound (XIX) payload
Undisclosed
PSMA-B Antibody-Compound (XIX) linker
PSMA-B Antibody-Compound (Ii) [18]
PSMA-B Antibody-Compound (Ii) payload
Undisclosed
PSMA-B Antibody-Compound (Ii) linker
PSMA-B Antibody-Compound (XLI) [18]
PSMA-B Antibody-Compound (XLI) payload
Undisclosed
PSMA-B Antibody-Compound (XLI) linker
PSMA-B Antibody-Compound (XVI) [18]
PSMA-B Antibody-Compound (XIX) payload
Undisclosed
PSMA-B Antibody-Compound (XIX) linker
PSMA-B Antibody-Compound (XL) [18]
PSMA-B Antibody-Compound (XL) payload
Undisclosed
PSMA-B Antibody-Compound (XL) linker
PSMA-B Antibody-Compound (XLIII) [18]
PSMA-B Antibody-Compound (XLIII) payload
Undisclosed
PSMA-B Antibody-Compound (XLIII) linker
PSMA-B Antibody-Compound (XLII) [18]
PSMA-B Antibody-Compound (XLII) payload
Undisclosed
PSMA-B Antibody-Compound (XLII) linker
PSMA-B Antibody-Compound (XV) [18]
PSMA-B Antibody-Compound (XV) payload
Undisclosed
PSMA-B Antibody-Compound (XV) linker
PSMA-C Anti-ody
ADC Name Payload Target Linker ADC Info
PSMA-C Antibody-Compound (X) [18]
PSMA-C Antibody-Compound (X) payload
Undisclosed
PSMA-C Antibody-Compound (X) linker
PSMA-C Antibody-Compound (XI) [18]
PSMA-C Antibody-Compound (XI) payload
Undisclosed
PSMA-C Antibody-Compound (XI) linker
PSMA-C Antibody-Compound (XIV) [18]
PSMA-C Antibody-Compound (XIV) payload
Undisclosed
PSMA-C Antibody-Compound (XIV) linker
PSMA-C Antibody-Compound (XVIII) [18]
PSMA-C Antibody-Compound (XVIII) payload
Undisclosed
PSMA-C Antibody-Compound (XVIII) linker
PSMA-C Antibody-Compound (Ie) [18]
PSMA-C Antibody-Compound (Ie) payload
Undisclosed
PSMA-C Antibody-Compound (Ie) linker
PSMA-C Antibody-Compound (XIX) [18]
PSMA-C Antibody-Compound (XIX) payload
Undisclosed
PSMA-C Antibody-Compound (XIX) linker
PSMA-C Antibody-Compound (Ii) [18]
PSMA-C Antibody-Compound (Ii) payload
Undisclosed
PSMA-C Antibody-Compound (Ii) linker
PSMA-C Antibody-Compound (XLI) [18]
PSMA-C Antibody-Compound (XLI) payload
Undisclosed
PSMA-C Antibody-Compound (XLI) linker
PSMA-C Antibody-Compound (XVI) [18]
PSMA-C Antibody-Compound (XIX) payload
Undisclosed
PSMA-C Antibody-Compound (XIX) linker
PSMA-C Antibody-Compound (XL) [18]
PSMA-C Antibody-Compound (XL) payload
Undisclosed
PSMA-C Antibody-Compound (XL) linker
PSMA-C Antibody-Compound (XLIII) [18]
PSMA-C Antibody-Compound (XLIII) payload
Undisclosed
PSMA-C Antibody-Compound (XLIII) linker
PSMA-C Antibody-Compound (XLII) [18]
PSMA-C Antibody-Compound (XLII) payload
Undisclosed
PSMA-C Antibody-Compound (XLII) linker
PSMA-C Antibody-Compound (XV) [18]
PSMA-C Antibody-Compound (XV) payload
Undisclosed
PSMA-C Antibody-Compound (XV) linker
Rosopatamab
ADC Name Payload Target Linker ADC Info
Rosopatamab tetraxetan [19]
Y90 (Radioactive isotope)
Undisclosed
Tetraxetan
Undisclosed
ADC Name Payload Target Linker ADC Info
Anti-PSMA antibody-drug conjugate (Protanbio) [20]
Undisclosed
Undisclosed
Undisclosed
PSMA ADC (Jiangsu hengrui) [21]
Undisclosed
Undisclosed
Undisclosed
Anti-PSMA antibody-deBouganin fusion protein (Crescendo/Sesen Bio) [22]
Undisclosed
Undisclosed
Undisclosed
HDP-103 [23]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Undisclosed
DAN-405 [24]
Cabazitaxel
Microtubule (MT)
Undisclosed
MMAE.VC.SA.617 [25]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Anti-PSMA antibody-drug conjugate [26]
Undisclosed
Undisclosed
Undisclosed
CB-108 [27]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot41 [28]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot42 [28]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot55 [28]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot75 [28]
Undisclosed
Undisclosed
Undisclosed
References
Ref 1 Development and therapeutic evaluation of 5D3(CC-MLN8237)(3.2) antibody-theranostic conjugates for PSMA-positive prostate cancer therapy
Ref 2 Monoclonal antibody 7E11 C5-selenocystamine conjugate; 29 Apr 2002.
Ref 3 Non-linear self-immolative linkers and conjugates thereof
Ref 4 Preclinical development of MHB048C: A novel anti-PSMA ADC with a potent topoisomerase I inhibitor
Ref 5 Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors. J Nucl Med. 2018 Mar;59(3):494-501. doi: 10.2967/jnumed.117.196279. Epub 2017 Nov 16.
Ref 6 Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids. Bioorg Med Chem. 2018 May 15;26(9):2271-2279. doi: 10.1016/j.bmc.2018.02.025. Epub 2018 Feb 21.
Ref 7 Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen. J Nucl Med. 2019 Mar;60(3):400-406. doi: 10.2967/jnumed.118.214403. Epub 2018 Sep 20.
Ref 8 Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress. Drug Discov Today. 2021 Aug;26(8):1857-1874. doi: 10.1016/j.drudis.2021.06.012. Epub 2021 Jul 3.
Ref 9 Amatoxin antibody-drug conjugates and uses thereof; 2020-10-29.
Ref 10 In Vitro Evaluation of Humanized/De-immunized Anti-PSMA Immunotoxins for the Treatment of Prostate Cancer. Anticancer Res. 2018 Jan;38(1):61-69. doi: 10.21873/anticanres.12192.
Ref 11 Site-specific conjugation of linker drugs to antibodies and resulting adcs.
Ref 12 Anti-PSMA (124)I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle. J Exp Clin Cancer Res. 2019 Jul 23;38(1):326. doi: 10.1186/s13046-019-1325-6.
Ref 13 Novel anti-prostate-specific membrane antigen (PSMA) antibody drug conjugates
Ref 14 Preclinical evaluation of SDV2102, a novel PSMA-targeting DAR1 ADC for mCRPC treatment
Ref 15 Improved tumor penetration and cytotoxic payload release with TD001, a novel PSMA-targeting ADC with optimized linker-payload composition, in PSMA-expressing CRPC CDX castrated mouse models
Ref 16 Anti-PSMA antibody-drug conjugates and their preparation methods and applications
Ref 17 In Silico-Driven THIOMAB Approach for Stable PROTAC Conjugates by Docking Payloads in Antibody Cavities
Ref 18 Linkers for use in antibody drug conjugates; 2023-03-16.
Ref 19 ADC review ROSOPATAMAB TETRAXETAN
Ref 20 Introduction to basic information on anti PRLR anti-PSMA antibody-drug conjugate(Protanbio).
Ref 21 Introduction to basic information on ADC drug PSMA ADC (Jiangsu hengrui)
Ref 22 Engineering and characterization of anti-PSMA humabody-deBouganin fusion proteins. Cancer Res (2018) 78 (13_Supplement): 5770.
Ref 23 Heidelberg pharma product pipeline
Ref 24 Dantari biotechnology company product pipeline
Ref 25 Old Drug, New Delivery Strategy: MMAE Repackaged. Int J Mol Sci. 2023 May 10;24(10):8543. doi: 10.3390/ijms24108543.
Ref 26 Introduction to basic information on ADC drug Anti-PSMA antibody-drug conjugates(Medarex)
Ref 27 Multifunctional biologics for targeted T-cell therapy based on in vivo matured fully human VH domains. Cancer Res (2018) 78 (13_Supplement): 5766.
Ref 28 TLR7 agonists and antibody-drug conjugates thereof